Curative by Design™

Our Team Has The Expertise To Make
T Cell Therapy A Curative Reality

Verik's founders represent the rare combination of cutting-edge scientist and insightful applied biologist.

Creating a novel cancer immunotherapy is both and an art and science that requires far more than academic knowledge. Having learned from the pioneering achievement of advancing the first
FDA-approval of a living cell therapy to market, Verik’s founders
are poised to succeed once again with the help of a  team of experienced, savvy professionals.

Nancy L. Parenteau, Ph.D.

  • Co-founder, Chair, President and CSO  more

    • Nancy is an internationally recognized thought leader and C-level executive in translation and commercialization of regenerative medicine.

    • She was the principal scientist responsible for the first US approved living cell therapy, a bioengineered living skin equivalent (Apligraf®, Organogenesis Inc.), the most successful commercial cell therapy to date, with 3 FDA approvals.


    •  She rose to prominence in the tissue engineering field during her fifteen years at Organogenesis Inc. ultimately becoming its Senior Vice President and CSO.

    • Nancy received her degree in cell and developmental biology and anatomy from Georgetown University School of Medicine and trained in epithelial biology and carcinoma as a Harvard postdoc.

Joseph C. Laning, Ph.D.

  • Co-founder,  VP Molecular Immunology more

    • Joe is a molecular immunologist and stem cell biologist who has pioneered analytical testing programs for oncologic and tissue repair cell therapies.

    • He developed, validated, and received IND approval for novel cGMP cell therapy manufacturing processes targeting hematopoietic cancer.

    • He gained broad translational experience in cell-based technologies from his work at Organogenesis, Amaranth Bio, ViaCell, and Provia Labs.

    • Joe received his degree in Molecular Immunology from Harvard.

Janet H. Young, Ph.D.

  • Co-founder,  VP Translational Biology more

    •  A cellular immunologist, Jan established preclinical and clinical safety platform for first allogeneic cell therapy, now an FDA benchmark.

    • She gained valuable preclinical, analytical, clinical and post-marketing study experience while at Organogenesis Inc.

    • Jan trained in B cell immunology as a postdoc at the University of Georgia and Harvard.

    • She received her degree in immunology from Georgia Tech.


Susan J. Sullivan, Ph.D.

  • VP Operations more

    • Susan is a cell biologist with over 25 years of experience in cell-based therapies and targeted oncology product development.

    • She is an accomplished product developer and skilled life science manager with a proven track record of building and mentoring high performance teams.

    • Susan has extensive alliance management experience in immune-oncology working with major pharma and Biotech companies to bring ten products using ImmunoGen’s ADC technology into clinical development.

    • She received her degree in cell biology from the University of Pennsylvania and did her postdoctoral training at Harvard.


© 2018 Verik Bio, Inc
website design by Alice Sargent